News tagged with cancer vaccine
(Medical Xpress)—Scientists at the School of Medicine have shown that their previously identified therapeutic approach to fight cancer via immune cells called macrophages also prompts the disease-fighting killer T cells ...
Cancer May 21, 2013 | 5 / 5 (1) | 0 |
A new Boston University School of Medicine (BUSM) study has found that low-income and minority parents may be more receptive to vaccinating their daughters against Human Papillomavirus (HPV), while white, middle-class parents ...
Cancer May 14, 2013 | not rated yet | 0
In the summer of 1968, a new strain of influenza appeared in Hong Kong. This strain, known as H3N2, spread around the globe and eventually killed an estimated 1 million people.
Diseases, Conditions, Syndromes May 10, 2013 | not rated yet | 0 |
Social stigma is harming attempts to combat cervical cancer in India where more women die annually of the disease than anywhere else in the world, a new report said Friday.
Cancer May 10, 2013 | not rated yet | 0
Two multinational drugmakers are teaming up with top global health groups to protect millions of girls in the world's poorest countries from deadly cervical cancer.
Medications May 09, 2013 | not rated yet | 0
The HPV vaccine can prevent both cervical cancer and a nasty sexually transmitted disease in women. But emphasizing the STD prevention will persuade more young women to get the vaccine, a new study suggests.
Health May 02, 2013 | 5 / 5 (1) | 0
With the number of doses and cost of human papillomavirus (HPV) vaccines a barrier to global implementation, researchers have found that girls who received two doses of HPV vaccine had immune responses to HPV-16 and HPV-18 ...
Cancer Apr 30, 2013 | not rated yet | 0
At present over one hundred strains of the human papillomavirus (HPV) are known, fourteen of which can trigger cancer. The HPV vaccinations currently in use provide protection from 70 percent of these cancers. ...
Obstetrics & gynaecology Apr 17, 2013 | 5 / 5 (1) | 0
The Supreme Court grapples Monday with the question of whether human genes can be patented, and the ultimate answer could reshape U.S. medical research, the fight against diseases like breast and ovarian ...
Genetics Apr 15, 2013 | 5 / 5 (1) | 1
As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma (HCC) or liver cancer. Pexa-Vec ...
Cancer Apr 10, 2013 | 5 / 5 (2) | 0
It's generally thought that anticancer chemotherapies work like antibiotics do, by directly killing off what's harmful. But new research published online on April 4 in the Cell Press journal Immunity shows that effective chemot ...
Immunology Apr 04, 2013 | 4.5 / 5 (2) | 0
Researchers at Moffitt Cancer Center and colleagues at the University of Florida studied health care providers to determine the factors associated with disparities in Human Papillomavirus (HPV) vaccination among girls, ages ...
Cancer Mar 27, 2013 | not rated yet | 0
Wageningen University in the Netherlands has developed a prototype vaccine against chikungunya in a joint effort with the Erasmus Medical Centre and TI Pharma. This prototype may hopefully lead to the first working vaccine ...
Diseases, Conditions, Syndromes Mar 21, 2013 | not rated yet | 0
By charting the differing fates of individual T cells, researchers have shown that previously unpredictable aspects of the adaptive immune response can be effectively modeled. The crucial question: What determines ...
Medical research Mar 20, 2013 | 5 / 5 (2) | 0 |
A rising percentage of parents say they won't have their teen daughters vaccinated to protect against the human papilloma virus, even though physicians are increasingly recommending adolescent vaccinations, a study by Mayo ...
Pediatrics Mar 18, 2013 | 5 / 5 (3) | 1
The term cancer vaccine refers to a vaccine that either prevents infections with cancer-causing viruses, treats existing cancer or prevents the development of cancer in certain high risk individuals.
Some cancers, such as cervical cancer and some liver cancers, are caused by viruses, and traditional vaccines against those viruses, such as HPV vaccine and Hepatitis B vaccine, will prevent those cancers.
Scientists have also been trying to develop vaccines against existing cancers. Some researchers believe that cancer cells routinely arise and are destroyed by the healthy immune system; cancer forms when the immune system fails to destroy them. One approach to cancer vaccination is to separate proteins from cancer cells and immunize cancer patients against those proteins, in the hope of stimulating an immune reaction that would kill the cancer cells. Therapeutic cancer vaccines are being developed for the treatment of breast, lung, colon, skin, kidney, prostate, and other cancers..
On April 14 2009 Dendreon Corporation announced that their Phase III clinical trial of Provenge, a cancer vaccine designed to treat prostate cancer, had succeeded in demonstrating an increase in survival. This is the first robust, statistically significant Phase III result for a cancer vaccine, although the data have yet to be scrutinized by the U.S. Food and Drug Administration or by European Union regulatory agencies. Dendreon is forecasting marketing approval by the FDA by 2010
If Provenge is approved by the FDA, Dendreon will have opened a new era in cancer care.
For more information about Cancer vaccine, read the full article at
This text uses material from Wikipedia and is available under the GNU Free Documentation License.